NMO SPECTRUM DISORDER
Clinical trials for NMO SPECTRUM DISORDER explained in plain language.
Never miss a new study
Get alerted when new NMO SPECTRUM DISORDER trials appear
Sign up with your email to follow new studies for NMO SPECTRUM DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks antibody drugs for rare nerve disease in 200 patients
Disease control Recruiting nowThis study is tracking how well different monoclonal antibody treatments work for people with a rare autoimmune disease called neuromyelitis optica spectrum disorder (NMOSD). The disease causes the immune system to attack the nerves in the eyes and spine. The study will follow 20…
Matched conditions: NMO SPECTRUM DISORDER
Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug B001 aims to tame rare nerve disease NMOSD in early trial
Disease control Recruiting nowThis study tests a new medicine called B001 in 45 adults with a specific type of NMOSD, a rare disease where the immune system attacks the nerves. The main goal is to check if B001 is safe and how the body processes it. Researchers will also look for early signs that it might hel…
Matched conditions: NMO SPECTRUM DISORDER
Phase: EARLY_PHASE1 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Zapping away pain: new brain stimulation trial for NMOSD sufferers
Symptom relief Recruiting nowThis study tests a gentle, non-invasive brain stimulation method called tTIS to see if it can reduce nerve pain in people with NMOSD. Twelve adults with stable treatment and ongoing pain for at least 3 months will receive the stimulation and be monitored for changes in pain score…
Matched conditions: NMO SPECTRUM DISORDER
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC
-
AI set to revolutionize MS diagnosis and treatment monitoring
Knowledge-focused Recruiting nowThis study collects health data from 7000 people with multiple sclerosis (MS) and related conditions. The goal is to use this information to train artificial intelligence (AI) tools that can help doctors diagnose MS earlier and predict how the disease will progress. Participants …
Matched conditions: NMO SPECTRUM DISORDER
Sponsor: icometrix • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC